Nisa Investment Advisors’s Kite Pharma, Inc. KITE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-620
Closed -$111K 1883
2017
Q3
$111K Hold
620
﹤0.01% 1354
2017
Q2
$64K Buy
620
+140
+29% +$11.4K ﹤0.01% 1396
2017
Q1
$38K Sell
480
-120
-20% -$7.42K ﹤0.01% 1454
2016
Q4
$27K Hold
600
﹤0.01% 1552
2016
Q3
$34K Buy
600
+200
+50% +$11.1K ﹤0.01% 1482
2016
Q2
$20K Hold
400
﹤0.01% 1618
2016
Q1
$18K Buy
+400
New +$19.4K ﹤0.01% 1652

Nisa Investment Advisors's KITE Position: Q4 2017 in Review

Nisa Investment Advisors sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 620 shares — an estimated $111K sold.

Nisa Investment Advisors first reported a position in KITE in Q1 2016 and held it in 7 quarters. The position peaked at $111K in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • Nisa Investment Advisors reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • Nisa Investment Advisors sold 620 Kite Pharma, Inc. shares in Q4 2017, an estimated $111K.
  • Nisa Investment Advisors first reported a position in Kite Pharma, Inc. in Q1 2016 and held it in 7 quarters.
  • Nisa Investment Advisors's Kite Pharma, Inc. position peaked at $111K in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Nisa Investment Advisors's 13F filing for Q4 2017, filed 12 Jan 2018.